| Literature DB >> 17339318 |
Alexandra Grosfeld1, Ineke P Stolze, Matthew E Cockman, Christopher W Pugh, Mariola Edelmann, Benedikt Kessler, Alex N Bullock, Peter J Ratcliffe, Norma Masson.
Abstract
The von Hippel-Lindau tumor suppressor (pVHL) targets hydroxylated alpha-subunits of hypoxia-inducible factor (HIF) for ubiquitin-mediated proteasomal destruction through direct interaction with the hydroxyproline binding pocket in its beta-domain. Although disruption of this process may contribute to VHL-associated tumor predisposition by up-regulation of HIF target genes, genetic and biochemical analyses support the existence of additional functions, including a role in the assembly of extracellular matrix. In an attempt to delineate these pathways, we searched for novel pVHL-binding proteins. Here we report a direct, hydroxylation-dependent interaction with alpha-chains of collagen IV. Interaction with pVHL was also observed with fibrillar collagen chains, but not the folded collagen triple helix. The interaction was suppressed by a wide range of tumor-associated mutations, including those that do not disturb the regulation of HIF, supporting a role in HIF-independent tumor suppressor functions.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17339318 DOI: 10.1074/jbc.M611648200
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157